Home › Funds › Equitable › 1290 VT Micro Cap Portfolio
Fund family: Equitable · Filed by EQ ADVISORS TRUST (CIK 1027263) · SEC series S000044688
“With management” counts the items where the fund’s own filing gives management’s recommendation (FOR or AGAINST): 9,840 with, 18 against, 0 abstentions (not counted as with management); 3 items carried no recommendation; 10 split votes are in neither count. Shareholder proposals: 4 FOR, 9 AGAINST, 0 abstained, by the filing’s own vote-source field.
The same two figures as Equitable’s manager page (393,894 ballot items across 72 funds and accounts), counted the same way for this fund.
| 2025-2026 | This fund | Items | Equitable | Items |
|---|---|---|---|---|
| Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters) | 90.6% | 9,472 | 92.5% | 339,726 |
| Backed environmental and social shareholder proposals at US companies | n/a | 1 | 9.6% | 3,486 |
Each ballot item this fund voted is set against the votes of the other Equitable funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.
Voted differently from most Equitable funds on 17 items (0.2% of the 7,168 items where a comparison was possible).
| Company | Meeting | Item | This fund | Most Equitable funds | Mgmt | Result |
|---|---|---|---|---|---|---|
| OSI Systems, Inc. | 2025-12-11 | Advisory vote to approve the Company's named executive officer compensation for the fiscal year ended June 30, 2025. | Against | FOR — 8 of 8 Equitable funds | Against | Passed (calculated), 81.0% support |
| Calix, Inc. | 2026-05-14 | Shareholder To hold an advisory vote on a stockholder proposal relating to a simple majority vote. | Against | FOR — 8 of 8 Equitable funds | For | Passed (calculated), 90.8% support |
| Genius Sports Limited | 2025-12-10 | Re-elect Daniel Burns as Director | For | AGAINST — 7 of 7 Equitable funds | For | — |
| Navan, Inc. | 2026-06-25 | The election of the three Class I director nominees listed below: Ben Horowitz | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 98.3% support |
| Navan, Inc. | 2026-06-25 | The election of the three Class I director nominees listed below: Michael Kourey | For | WITHHOLD — 5 of 5 Equitable funds | For | Elected, 98.4% support |
| Kestra Medical Technologies, Ltd. | 2025-09-03 | The approval of the Kestra Medical Technologies, Ltd. 2025 Employee Stock Purchase Plan. | For | AGAINST — 4 of 6 Equitable funds | For | — |
| GPGI, Inc. | 2026-06-11 | Election of Directors: Brian F. Hughes | Withhold | FOR — 5 of 9 Equitable funds | Against | Passed (calculated), 97.8% support |
| 10x Genomics, Inc. | 2026-06-04 | Election of the Class I directors listed in the accompanying proxy statement, to serve a three-year term expiring at the 2029 annual meeting of stockholders or until each such director's successor is duly elected and qualified or until each such director's earlier death, resignation, disqualificatio | Against | FOR — 4 of 7 Equitable funds | Against | Passed (calculated), 86.6% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: Lon Cardon, Ph.D., FMedSci | Withhold | FOR — 4 of 7 Equitable funds | Against | Elected, 85.3% support |
| Mirum Pharmaceuticals, Inc. | 2026-06-15 | To elect the Board's three Class I nominees for director to hold office until the Company's 2029 annual meeting of stockholders and their successors are duly elected and qualified, or until their earlier death, resignation or removal: William Fairey | Withhold | FOR — 4 of 7 Equitable funds | Against | Elected, 86.8% support |
| Calix, Inc. | 2026-05-14 | To elect each of the three director nominees named in the proxy statement: Kathleen Crusco | For | WITHHOLD — 4 of 7 Equitable funds | For | Passed (calculated), 90.7% support |
| Xometry, Inc. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Fabio Rosati | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 90.0% support |
| Xometry, Inc. | 2026-06-16 | To elect three Class II directors, each to hold office until the Company's Annual Meeting of Stockholders in 2029: Katharine Weymouth | Withhold | FOR — 3 of 5 Equitable funds | Against | Elected, 86.7% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | Election of Directors: Aylwin Lewis | For | AGAINST — 3 of 5 Equitable funds | For | Passed (calculated), 73.2% support |
| The Chefs' Warehouse, Inc. | 2026-05-08 | To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement. | For | AGAINST — 3 of 5 Equitable funds | For | Approved, 51.0% support |
| Sphere Entertainment Co. | 2026-06-10 | Election of the following nominees as directors: Debra G. Perelman | Withhold | FOR — 2 of 3 Equitable funds | Against | Elected, 81.7% support |
| Sphere Entertainment Co. | 2026-06-10 | Election of the following nominees as directors: Joel M. Litvin | Withhold | FOR — 2 of 3 Equitable funds | Against | Elected, 81.6% support |
Download all 17 differences (CSV)
The same votes as “with management” above, by the sector of the company voted on. 69.3% of this fund’s 9,858 such votes could be given a sector; the other 3,027 (30.7%) are at companies without one and are not in the table.
| Sector | Votes | Against management | Share |
|---|---|---|---|
| Finance | 1,684 | 4 | 0.2% |
| Health Care | 1,440 | 1 | 0.1% |
| Consumer Discretionary | 1,211 | 6 | 0.5% |
| Industrials | 786 | 0 | 0.0% |
| Technology | 733 | 2 | 0.3% |
| Real Estate | 294 | 1 | 0.3% |
| Energy | 188 | 0 | 0.0% |
| Utilities | 129 | 0 | 0.0% |
| Basic Materials | 127 | 0 | 0.0% |
| Consumer Staples | 99 | 3 | 3.0% |
| Telecommunications | 85 | 0 | 0.0% |
| Miscellaneous | 55 | 0 | 0.0% |
| Proposal type | Items | Against management |
|---|---|---|
| Director Elections | 6,376 | 8 |
| Audit-related | 1,274 | 0 |
| Say-on-Pay | 1,168 | 0 |
| Compensation | 493 | 0 |
| Corporate Governance | 324 | 4 |
| Capital Structure | 244 | 2 |
| Extraordinary Transactions | 124 | 3 |
| Shareholder Rights and Defenses | 38 | 0 |
| Other | 11 | 0 |
| Other Social Issues | 3 | 0 |
Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.
| Company | Meeting | Est. position | Items | Against mgmt |
|---|---|---|---|---|
| Adaptive Biotechnologies Corporation | June 5, 2026 | $5M | 4 | 0 |
| Cogent Biosciences, Inc. | June 9, 2026 | $3M | 5 | 0 |
| Lindblad Expeditions Holdings, Inc. | June 10, 2026 | $3M | 6 | 0 |
| Praxis Precision Medicines, Inc. | June 10, 2026 | $3M | 5 | 0 |
| Tarsus Pharmaceuticals, Inc. | June 25, 2026 | $3M | 6 | 0 |
| 10x Genomics, Inc. | June 4, 2026 | $2M | 5 | 0 |
| CRA International, Inc. | July 17, 2025 | $2M | 4 | 0 |
| Navan, Inc. | June 25, 2026 | $2M | 4 | 0 |
| Meeting | Company | Proposal | Fund | Mgmt |
|---|---|---|---|---|
| July 30, 2025 | Grindr Inc. | Stockholder proposal regarding adoption of a human rights policy covering freedom of association and collective bargaining. Shareholder proposal | Against | For |
| May 14, 2026 | Calix, Inc. | To hold an advisory vote on a stockholder proposal relating to a simple majority vote. Shareholder proposal | Against | For |
| May 26, 2026 | El Pollo Loco Holdings, Inc. | A Shareholder Proposal requesting the Adoption of a Majority Voting Standard for the Election of Directors in Uncontested Elections. Shareholder proposal | For | Against |
| May 26, 2026 | Bel Fuse Inc. | With respect to a shareholder proposal requesting that our board of directors take all necessary steps to provide the holders of Class A Common Stock with the right to convert their shares into Class B Common Stock at their option at any time, if properly presented at the Annual Meeting Shareholder proposal | Against | For |
| June 9, 2026 | Medallion Financial Corp. | ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS ZIMCAL ASSET MANAGEMENT LLC, NOMINEES: Eric Kelly Shareholder proposal | Withhold | For |
| June 9, 2026 | Medallion Financial Corp. | ELECTION OF DIRECTORS - TO ELECT THREE (3) CLASS III DIRECTORS, EACH FOR A TERM EXPIRING AT THE 2029 ANNUAL MEETING OF STOCKHOLDERS ZIMCAL ASSET MANAGEMENT LLC, NOMINEES: John Kiernan Shareholder proposal | For | Against |
| June 2, 2026 | NexPoint Diversified Real Estate Trust | If properly presented at the annual meeting, to vote on the shareholder proposal presented under the heading "Shareholder Proposal" in the proxy statement. a. Please note the board is recommending a vote against the shareholder proposal. Shareholder proposal | Against | For |
| December 29, 2025 | Lifeway Foods, Inc. | Election of Directors: Opposition Nominees: George Sent Shareholder proposal | Withhold | For |
| December 29, 2025 | Lifeway Foods, Inc. | Election of Directors: Opposition Nominees: Edward Smolyansky Shareholder proposal | Withhold | For |
| June 18, 2026 | Genco Shipping & Trading Limited | Election of Directors Diana Nominees OPPOSED by the Company: Paul Cornell Shareholder proposal | Withhold | For |
| June 18, 2026 | Genco Shipping & Trading Limited | Election of Directors Diana Nominees OPPOSED by the Company: Jens Ismar Shareholder proposal | Withhold | For |
| May 29, 2026 | Forte Biosciences, Inc. | To elect three (3) Class III directors to hold office until our 2029 annual meeting of stockholders and until his or her respective successors are elected and qualified: Steven Kornfeld | For | Against |
Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.
10,058 ballot items at 1,441 meetings in 2025-2026. Download all votes (CSV)
Recent votes against management’s recommendation at large companies.
In the 2025-2026 proxy season, 1290 VT Micro Cap Portfolio voted at 1,441 shareholder meetings of 1,338 companies, on 10,058 ballot items in all. Where management made a recommendation, the fund followed it on 99.8% of the items and voted against it 18 times. Its most frequent area of disagreement was director elections (8 of its votes against management). It voted on 19 shareholder proposals. It voted FOR the board's own proposals less often than Equitable's funds as a whole (90.6% against 92.5%). It voted differently from most Equitable funds on 17 items. 4 of its meetings were contested.
Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 18, 2026; the family figures are those of Equitable’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.